GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Strata Skin Sciences Inc (FRA:E2O) » Definitions » Cyclically Adjusted PS Ratio

Strata Skin Sciences (FRA:E2O) Cyclically Adjusted PS Ratio : 0.07 (As of Jun. 20, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Strata Skin Sciences Cyclically Adjusted PS Ratio?

As of today (2024-06-20), Strata Skin Sciences's current share price is €3.76. Strata Skin Sciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €51.57. Strata Skin Sciences's Cyclically Adjusted PS Ratio for today is 0.07.

The historical rank and industry rank for Strata Skin Sciences's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:E2O' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.06   Med: 0.37   Max: 83.17
Current: 0.06

During the past years, Strata Skin Sciences's highest Cyclically Adjusted PS Ratio was 83.17. The lowest was 0.06. And the median was 0.37.

FRA:E2O's Cyclically Adjusted PS Ratio is ranked better than
97.29% of 479 companies
in the Medical Devices & Instruments industry
Industry Median: 2.12 vs FRA:E2O: 0.06

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Strata Skin Sciences's adjusted revenue per share data for the three months ended in Mar. 2024 was €1.772. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €51.57 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Strata Skin Sciences Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Strata Skin Sciences's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Strata Skin Sciences Cyclically Adjusted PS Ratio Chart

Strata Skin Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.39 0.31 0.31 0.15 0.10

Strata Skin Sciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.18 0.11 0.10 0.07

Competitive Comparison of Strata Skin Sciences's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Strata Skin Sciences's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Strata Skin Sciences's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Strata Skin Sciences's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Strata Skin Sciences's Cyclically Adjusted PS Ratio falls into.



Strata Skin Sciences Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Strata Skin Sciences's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=3.76/51.57
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Strata Skin Sciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Strata Skin Sciences's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.772/131.7762*131.7762
=1.772

Current CPI (Mar. 2024) = 131.7762.

Strata Skin Sciences Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 1.596 100.560 2.091
201409 1.625 100.428 2.132
201412 2.590 99.070 3.445
201503 0.581 99.621 0.769
201506 2.804 100.684 3.670
201509 39.238 100.392 51.505
201512 42.872 99.792 56.613
201603 25.726 100.470 33.742
201606 29.818 101.688 38.641
201609 32.336 101.861 41.833
201612 26.717 101.863 34.563
201703 30.440 102.862 38.997
201706 32.356 103.349 41.256
201709 24.645 104.136 31.186
201712 19.457 104.011 24.651
201803 12.392 105.290 15.509
201806 4.606 106.317 5.709
201809 2.214 106.507 2.739
201812 2.348 105.998 2.919
201903 2.157 107.251 2.650
201906 2.180 108.070 2.658
201909 2.064 108.329 2.511
201912 2.433 108.420 2.957
202003 1.837 108.902 2.223
202006 1.061 108.767 1.285
202009 1.412 109.815 1.694
202012 1.634 109.897 1.959
202103 1.448 111.754 1.707
202106 1.785 114.631 2.052
202109 1.919 115.734 2.185
202112 2.332 117.630 2.612
202203 1.843 121.301 2.002
202206 2.481 125.017 2.615
202209 2.738 125.227 2.881
202212 2.882 125.222 3.033
202303 2.028 127.348 2.099
202306 2.183 128.729 2.235
202309 2.376 129.860 2.411
202312 2.275 129.419 2.316
202403 1.772 131.776 1.772

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Strata Skin Sciences  (FRA:E2O) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Strata Skin Sciences Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Strata Skin Sciences's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Strata Skin Sciences (FRA:E2O) Business Description

Traded in Other Exchanges
Address
5 Walnut Grove Drive, Suite 140, Horsham, PA, USA, 19044
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United states.

Strata Skin Sciences (FRA:E2O) Headlines

No Headlines